Home > Products > Novel inhibitors
Cat. No. Product name CAS No.
DCC2024 Et-kuq

Novel enhancer of the religation reaction of human topoisomerase I

1393489-04-7
DCC2025 et-nhp5g

Partial agonist at the glutamate binding site of the GluN2 subunits

1040283-98-4
DCC2026 Etoxazole

Pesticide, acting as antibiotics or growth regulators to kill mites and ticks

153233-91-1
DCC2027 etp-45299

Potent and selective inhibitor of Pim 1, inhibiting the phosphorylation of Bad and 4EBP1 in cells and suppresses the proliferation of several non-solid and solid human tumor cell lines.

1150566-95-2
DCC2028 Etx2514

Novel broad-spectrum β-lactamase inhibitor

467157-21-6
DCC2029 Eu1622-14

Novel Biased modulator of NMDA receptors, controlling channel opening and ion selectivity

DCC2030 Eu1794-4

Novel negative allosteric modulator (NAM) of NMDA receptors, reducing both the overall current that flows following receptor activation and the flux of Ca2+ ion relative to monovalent cations

DCC2031 Euk-124

Scavenger for oxidative species such as peroxynitrite, superoxide, and hydrogen peroxide

186299-35-4
DCC2032 Evolidine

The first plant cyclic peptide with antibacterial and antifungal activity

DCC2033 Evp-0015962

Novel potent gamma-secretase modulator

1447811-26-8
DCC2034 Evt-101

Novel GluN2B antagonist, binding at the same GluN1/GluN2B dimer interface as ifenprodil but adopting a remarkably different binding mode involving a distinct subcavity and receptor interactions

1189088-41-2
DCC2035 Evt-201

Novel partial positive allosteric GABAA receptor modulator

308239-86-3
DCC2036 Ew-7203

Novel ALK5 inhibitor

1383123-98-5
DCC2037 Ex4-dnp Conjugate 7

Novel glucagon-like peptide 1 (GLP-1) receptor agonist, displaying significantly elongated half-lives and improved long-acting antidiabetic activity in the presence of endogenous anti-DNP antibodies

DCC2038 Ex-527(r)

Potent and selective SIRT1 inhibitor

848193-69-1
DCC2039 Ex-527(s)

Potent and selective SIRT1 inhibitor

848193-68-0
DCC2040 Exatecan Mesylate Dihydrate

Topoisomerase I inhibitor

197720-53-9
DCC2041 exosensor 517

Novel Dual-Analyte Fluorescent Chemosensor for Visualizing Neurotransmitter Exocytosis

1450623-29-6
DCC2042 Ex-tbdps-chc

Novel potent MCT1 inhibitor, exhibiting good single agent anticancer efficacy properties

DCC2043 Ezn-2208

Polyethylene glycol conjugate of SN38, acting as a topoisomerase I inhibitor,, exerting significant anti-leukaemia activity, overcoming ABCG2-mediated topotecan resistance

946062-05-1
DCC2044 F0045(s)

Novel influenza A hemagglutinin (HA) fusion inhibitor (EC 50 = 1.9 ± 0.3 μM), preventing HA from transitioning to the postfusion state at pH 5.0

DCC2045 F0371-0041

Novel antifungal agent against Candida albicans persister cells

Page 1314 / Total 1557 FirstPrevNextLastGoto